Northwestern Mutual Wealth Management
NTLA icon

Northwestern Mutual Wealth Management’s Intellia Therapeutics NTLA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$140K Buy
10,958
+1,772
+19% +$22.6K ﹤0.01% 2042
2025
Q4 		$82.6K Buy
9,186
+2,106
+30% +$29K ﹤0.01% 2218
2025
Q3 		$122K Buy
7,080
+1,970
+39% +$24.3K ﹤0.01% 1976
2025
Q2 		$47.9K Buy
5,110
+520
+11% +$4.27K ﹤0.01% 2274
2025
Q1 		$32.6K Buy
4,590
+1,655
+56% +$16.7K ﹤0.01% 2327
2024
Q4 		$34.2K Sell
2,935
-21
-0.7% -$328 ﹤0.01% 2325
2024
Q3 		$60.7K Buy
2,956
+183
+7% +$4.22K ﹤0.01% 2085
2024
Q2 		$62.1K Sell
2,773
-100
-3% -$2.38K ﹤0.01% 2007
2024
Q1 		$79K Buy
2,873
+993
+53% +$27.6K ﹤0.01% 1909
2023
Q4 		$57.3K Sell
1,880
-350
-16% -$10.1K ﹤0.01% 1997
2023
Q3 		$70.5K Sell
2,230
-92
-4% -$3.57K ﹤0.01% 1843
2023
Q2 		$94.7K Sell
2,322
-222
-9% -$9K ﹤0.01% 1746
2023
Q1 		$94.8K Buy
+2,544
New +$99.8K ﹤0.01% 1712
2022
Q3 		– Sell
-6
Closed – – 3302
2022
Q2 		$0 Buy
+6
New +$305 ﹤0.01% 3383
2019
Q2 		– Sell
-15
Closed – – 2644
2019
Q1 		$0 Buy
+15
New +$224 ﹤0.01% 2651

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northwestern Mutual Wealth Management's NTLA Position: Q1 2026 in Review

Northwestern Mutual Wealth Management increased its Intellia Therapeutics (NTLA) stake by 19% in Q1 2026, buying an estimated $22.6K and bringing the position to 10,958 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #2042.

Northwestern Mutual Wealth Management first reported a position in NTLA in Q1 2019 and has held it in 15 quarters since. 303 funds tracked by Wall St. Rank hold NTLA as of Q1 2026.

  • Northwestern Mutual Wealth Management held 10,958 shares of Intellia Therapeutics worth $140K as of Q1 2026.
  • Northwestern Mutual Wealth Management bought 1,772 Intellia Therapeutics shares in Q1 2026, an estimated $22.6K.
  • Intellia Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #2042 holding.
  • Northwestern Mutual Wealth Management first reported a position in Intellia Therapeutics in Q1 2019 and has held it in 15 quarters since.
  • 303 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.